Tag: KMX

CURR Form-4 Alert, Options & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR) – Form-4 Alert

We’re circling back around to CURR for a few different reasons today. Firstly, the company was featured in an article yesterday on Seeking Alpha that identified it as one of the 20 most undervalued stocks with ties to the cannabis sector. (>>View Article)

Additionally, whenever we are tracking a particular company and notice the submission of a Form-4 (insider buying) we always take note, and one came in yesterday. CEO Robert Davidson increased his position, which you can verify by perusing the form. (>>View Form-4)

Lastly, as were recently mentioning about CURR in a previous report, the company held a Zoom webcast last Thursday pertaining to its current strategic positioning and direction. You can now view the entirety of the presentation without registering, on YouTube, and we would suggest that our readers do just that at their first opportunity. (>>View CURR Webcast – Total Runtime, 35:38)
______

Please direct any investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com


Massive Options Success:

All of our options ideas from yesterday morning’s premarket report immediately bore fruit. We timed the bottom bounce on SWI perfectly as the stock ran 13% from 14.975-16.94, made a timely earnings play on NKE, and bet that the SPY, which was falling in the premarket, would rebound. The markets predictably dipped and ripped, and helped to provide all of the following intraday gain opportunities:

SWI 02/19 $12.50-17.50 Calls
$12.50: 3.97-5.30 (+34%)
$15: 2.25-3.80 (+69%)
$17.50: 1.80-2.60 (+44%)
_____

SPY 12/23 $365-367 Calls
$365: 1.95-4.80 (+146%)
$366: 1.54-4.10 (+166%)
$367: 1.12-3.39 (+202%)
_____

NKE Weekly (12/24) $142-145 Calls
$142: 2.71-6.40 (+136%)
$143: 2.09-5.59 (+167%)
$144: 1.78-4.90 (+175%)
$145: 1.38-4.20 (+204%)

In the case of the SPY and SWI, which are both gapping up big here in the premarket, we would expect to see our observed ranges and potential gains increase today.

_____

Fresh Options Idea:
KMX Weekly $99-97.50 Puts

Extended Watchlist:
BSRC, PTTN, AMLH, JNSH, GAXY, FDBL

Bottom-Watch Signal & More

The Cato Corp. CATO

With the coronavirus pandemic still raging, we’ve been forced to move away from our traditional technical-based trading methods and become more opportunistic. In the case of CATO, however, we have an interesting opportunity with the stock being pressed down to its lowest prices in over a decade, just yesterday.

We are always looking for stocks that are searching out new lows, and will observe carefully in the days and weeks ahead as CATO establishes its own bottom. The company announced at the beginning of last month that would reopen most of its stores.

ABM Industries Inc. ABM 

In yesterday’s premarket report, we signaled a pair of contract sets to put on watch in the ABM chain, and we did see some solid movement in those on the day. They were the ABM Weekly $30 & 35 Calls and both made notable increases, with an especially impressive performance coming from the $35’s.

ABM Weekly $30-35 Calls
$30: 5.00-8.60 (+72%)
$35: 1.11-4.00 (+260%)
_____

Fresh Ideas:
JBL Weekly $33.50-34.50 Calls*
KMX Weekly $98.50-100 Calls* 

*Please do not attempt to trade weekly options on a Friday unless you are an advanced level trader with access to disposable funds.

Extended Watchlist:
NGCG, MRGE, DECN, VYST, UONE, UONEK, SALM, NTN

Massive Form-4 Alert

Options Reviews

Yesterday morning, our primary order of business was to continue our commitment to bringing our readers as many solid quick-strike options ideas as we can. Not surprisingly, we were able to see some very nice opportunities in our designated targets.

Despite a mixed bag of bears and bulls, the volatile intraday swinging action of the markets made it possible to jump on big gains for each of them. Here were our top plays for the day and the total potential gains which could have been achieved.

SPY Weekly $244-242 Puts
$244: 1.30-2.89 (+122%)
$243: 1.08-2.49 (+131%)
$242.50: 1.04-2.37 (+128%)
$242: .97-2.19 (+126%)
______

KMX Weekly $50-55 Calls
$55: .50-3.90 (+680%)
$50: .30-2.03 (+577%)

Howard Hughes Corp. HHC – Fresh Options Idea

We want to place some options in the HHC chain on longer-term watch today after noticing some massive institutional insider buying that has come in near the stock’s recent lows, to the tune of $500M. You don’t sink those kind of funds into a stock unless you are supremely confident that its present level of support is rock solid. We are going to begin tracking the HHC 07/17 $50-60 Calls as a result.

Extended Watchlist:
BIEI, TPTW, MSTO, USRM, SPOM, AYTU

Sticking with SPY Puts

Solid Hits on the SPY

We try to formulate new options ideas for a given session as often as we can without forcing the issue, and on most days we produce at least one. Yesterday, we designated our sole set of new contracts to watch as the SPY Weekly $250-248 Puts, and thanks to a painful day for the markets, we were afforded the chance to score some pretty nice intraday gains.

Two out of three of those strike points translated into instant double-bag opportunities, with the third falling just 1% short of that mark, providing the following moves on the day: 

SPY Weekly $250-248 Puts
$250: 4.39-8.73 (+99%)
$249: 4.00-8.10 (+103%)
$248: 3.65-7.50 (+105%)
______

Fresh Ideas:
SPY Weekly $244-242 Puts
WBA Weekly $44-45 Calls
KMX Weekly $50-55 Calls


CytoDyn, Inc. CYDY

We began tracking CYDY on Tuesday morning, and in addition to making a nominal move on the chart, the company has also put out some coronavirus related press in the couple days. One of the company’s investigational drugs which is about to enter Phase 2b/3 trials, has demonstrated a promising level of  efficacy among severe COVID-19 patients.

The stock itself has run from 2.65-3.09 in the past couple of sessions, which marks a move of just 17% but we’re going to be interested to continue tracking its performance in light of the company’s announcements.

VANCOUVER, Washington, April 02, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the three-day effect of leronlimab in eight severely ill COVID-19 patients demonstrated a significant improvement in several important immunologic bio-markers.  Patient test data reveals improvement in cytokines, IL-6, and a trend toward the normalization of the CD4/CD8 ratio. (>>View Full PR)


Extended Watchlist:
GRYO, PNAT, ROTH, SOLI, CTYX, IPIX

Blue Horseshoe Stocks: Stock Updates & More

DURRECT Corp. DRRX

We began tracking DRRX last month, with our initial alert coming on the morning of 08/07. Subsequent to that report, the stock recorded a low of 1.22, and yesterday, reached a new high of 2.46.

That works out to a clean double-bag move of 102% in a matter of six weeks. The stock has been on the rise for two months now, so we’ll be interested to see where it will ultimately find itself.

Avadel Pharma Inc. AVDL

We freshly tagged AVDL in yesterday morning’s premarket report, and while it didn’t make our heads spin, the stock did produce a solid intraday gain on our first day of tracking it.

From a low of 4.13, the stock reached a high of 5.37 on the day, which registers as a 30% upswing. We’ll continue to keep it on our watchlist as we head into midweek.

Fresh Options Ideas:
KMX Weekly $88.50-90 Calls
RH 10/25 $165-160 Puts

Extended Watchlist:
GHSI, JAG, OGEN, ALDX, OSTK

Get Our FREE Daily Reports!

SUBSCRIBE